glp-1 ibs This study reviews existing research on the use of receptor agonists in managing GI diseases and finds that early evidence suggests these agents hold promise across multiple conditions. Read the full Frontiers | Improvement of irritable

The most detailed published percentages still come from the 48-week Phase 2 trial, while the TRIUMPH Phase 3 program is the source researchers are watching for larger-sample confirmation of common adverse events, discontinuation rates, and rare safety signals

Both play an essential role not only in the production of melatonin, but also in the circadian control of its release during the day and night

Which home medication is likely responsible for this presentation

Conclusion Is Glutathione Right for You

What If Nothing I Try Works Talk to your prescriber about combination strategies, behavioral support, or evaluation for an underlying condition like cortisol excess, hypothyroidism, or sleep apnea

BMJ 369:m997